Home › Cancro del colon › New York › New York City
Studi clinici su Cancro del colon a New York City, NY
22 studi su Cancro del colon cercano partecipanti presso sedi a New York City e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
In reclutamentoFase 3
- Memorial Sloan Kettering Cancer Center ( Site 0095), New York
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
In reclutamentoFase 3
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New York
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
In reclutamentoFase 1/2
- Columbia University, New York
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
In reclutamentoFase 1/2
- NYU Langone Health Perlmutter Cancer Center, New York
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
In reclutamentoFase 3
- Icahn School of Medicine At Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
In reclutamento
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
In reclutamentoFase 2/3
- Mount Sinai West, New York
- Mount Sinai Hospital, New York
- Manhattan Eye Ear and Throat Hospital, New York
- e altri 2
Shield Post-Approval Study Protocol
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- NYU Langone, New York
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
In reclutamentoFase 1
- Xencor Investigative Site, New York
- Xencor Investigative Site, New York
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
In reclutamentoFase 1
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Memorial Sloan Kettering Cancer Center 53rd street., New York
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
In reclutamentoFase 1/2
- NYU Langone Medical Center, New York
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
In reclutamentoFase 1
- Research Site, New York
- Research Site, New York
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
In reclutamentoFase 1
- NYU Langone, New York
- Memorial Sloan Kettering Cancer Center, New York
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
In reclutamentoFase 1/2
- Perlmutter Cancer Center at NYU Langone Health, New York
- Memorial Sloan-Kettering Cancer Center, New York
- Columbia University, New York
Brodalumab in the Treatment of Immune-Related Adverse Events
In reclutamentoFase 1
- Columbia University Irving Medical Center, New York
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
In reclutamentoStudio osservazionale
- NYU Langone Health, New York
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
In reclutamentoStudio osservazionale
- Memorial Sloan Kettering Cancer Center, New York
Phase II Trial of Lung Chemoemobolization
In reclutamentoFase 2
- Memorial Sloan Kettering Cancer Center, New York
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Memorial Sloan Kettering Cancer Center, New York
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
In reclutamentoFase 3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- e altri 1
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, New York
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
In reclutamentoFase 1/2
- NYU Langone Health, New York
Studi su Cancro del colon in altre città
- Boston, MA22 studi
- Houston, TX20 studi
- Los Angeles, CA16 studi
- Nashville, TN16 studi
- St. Louis, MO15 studi
- Arlington, VA15 studi
- Chicago, IL14 studi
- San Antonio, TX14 studi
- Baldwin Park, CA14 studi
- Baltimore, MD13 studi
- Tampa, FL13 studi
- Washington, DC12 studi
Altri studi a New York City
- Cancro al seno136 studi
- Cancro del polmone non a piccole cellule121 studi
- Cancro (tutti i tipi)109 studi
- Cancro alla prostata103 studi
- Cancro metastatico93 studi
- Cancro colorettale78 studi
- Cancro ovarico69 studi
- Cancro ai polmoni60 studi
- Mieloma multiplo60 studi
- Cancro pancreatico60 studi
- Cancro dell'endometrio52 studi
- Leucemia mieloide acuta51 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.